CAR--话题@MedSci

#CAR-#

459篇内容 | 2261人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781144, encodeId=dc581e81144f1, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【招募患者】首都医科大学附属友谊医院CD19 CAR-T细胞免疫治疗免费患者招募, objectType=article, longId=89529, objectId=d0808952958, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0808952958, replyNumber=0, likeNumber=61, createdTime=2017-12-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0808952958, moduleTitle=【招募患者】首都医科大学附属友谊医院CD19 CAR-T细胞免疫治疗免费患者招募, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0808952958)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781166, encodeId=fb361e8116633, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=JCO:依鲁替尼失败后，CLL患者采用CAR-T治疗可行吗？, objectType=article, longId=106345, objectId=ad8510634599, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8510634599, replyNumber=0, likeNumber=106, createdTime=2017-12-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8510634599, moduleTitle=JCO:依鲁替尼失败后，CLL患者采用CAR-T治疗可行吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad8510634599)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781180, encodeId=40161e81180a0, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM:报道！CAR-T让这种淋巴瘤的脑转移完全缓解, objectType=article, longId=111871, objectId=56bc1118e129, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56bc1118e129, replyNumber=0, likeNumber=77, createdTime=2017-11-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56bc1118e129, moduleTitle=NEJM:报道！CAR-T让这种淋巴瘤的脑转移完全缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56bc1118e129)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781190, encodeId=23191e811901d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cancer Discov：这项新发现有望减少CAR-T疗法副作用, objectType=article, longId=116342, objectId=22c711634248, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22c711634248, replyNumber=0, likeNumber=66, createdTime=2018-06-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22c711634248, moduleTitle=Cancer Discov：这项新发现有望减少CAR-T疗法副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22c711634248)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781157, encodeId=4e561e81157ed, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Nanotechnol：重磅！利用纳米颗粒在体内制造CAR-T细胞, objectType=article, longId=99064, objectId=03ed9906432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03ed9906432, replyNumber=0, likeNumber=75, createdTime=2018-03-24, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03ed9906432, moduleTitle=Nat Nanotechnol：重磅！利用纳米颗粒在体内制造CAR-T细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03ed9906432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781146, encodeId=2beb1e81146e4, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=FDA批准又一通用型CAR-T疗法进入临床试验, objectType=article, longId=91772, objectId=85b191e7297, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85b191e7297, replyNumber=0, likeNumber=121, createdTime=2017-09-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85b191e7297, moduleTitle=FDA批准又一通用型CAR-T疗法进入临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85b191e7297)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781150, encodeId=27ef1e8115006, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=诺华CAR- T疗法今日获美国FDA优先审评资格, objectType=article, longId=94099, objectId=468f940997e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=468f940997e, replyNumber=0, likeNumber=56, createdTime=2017-04-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=468f940997e, moduleTitle=诺华CAR- T疗法今日获美国FDA优先审评资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=468f940997e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781151, encodeId=ab531e811518d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=诺华CAR-T CTL019再获突破性疗法认定, objectType=article, longId=96403, objectId=ca1f96403c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca1f96403c9, replyNumber=0, likeNumber=71, createdTime=2017-08-12, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca1f96403c9, moduleTitle=诺华CAR-T CTL019再获突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca1f96403c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781142, encodeId=c1751e8114244, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T技术成功治愈两名ALL婴儿患者, objectType=article, longId=88766, objectId=5b8088e6609, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b8088e6609, replyNumber=0, likeNumber=51, createdTime=2017-03-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b8088e6609, moduleTitle=CAR-T技术成功治愈两名ALL婴儿患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b8088e6609)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781172, encodeId=b5051e81172dc, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T疗法上市之争已打响，全程自动化将是下一个爆发点, objectType=article, longId=107526, objectId=289310e526f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=289310e526f8, replyNumber=0, likeNumber=109, createdTime=2017-09-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=289310e526f8, moduleTitle=CAR-T疗法上市之争已打响，全程自动化将是下一个爆发点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=289310e526f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781191, encodeId=71dd1e81191d0, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=重磅！全球第二个CAR-T疗法获批上市！, objectType=article, longId=116808, objectId=f11b1168087d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f11b1168087d, replyNumber=0, likeNumber=84, createdTime=2017-12-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f11b1168087d, moduleTitle=重磅！全球第二个CAR-T疗法获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f11b1168087d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781143, encodeId=7b511e8114336, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature深度好文：女神告诉你，CRISPR让CAR-T继续“开车”, objectType=article, longId=88820, objectId=db0888820f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db0888820f0, replyNumber=0, likeNumber=64, createdTime=2017-09-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db0888820f0, moduleTitle=Nature深度好文：女神告诉你，CRISPR让CAR-T继续“开车”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db0888820f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781148, encodeId=ed671e8114876, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T疗法假如定价65万美元合理吗？, objectType=article, longId=92578, objectId=514b925e839, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=514b925e839, replyNumber=0, likeNumber=67, createdTime=2017-06-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=514b925e839, moduleTitle=CAR-T疗法假如定价65万美元合理吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=514b925e839)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781160, encodeId=08b81e81160bf, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=数据公布，诺华新一代CAR-T疗法CTL119取得优异疗效, objectType=article, longId=101046, objectId=c56d10104674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c56d10104674, replyNumber=0, likeNumber=87, createdTime=2017-11-13, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c56d10104674, moduleTitle=数据公布，诺华新一代CAR-T疗法CTL119取得优异疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c56d10104674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781129, encodeId=17cc1e81129a3, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Juno CD28 CAR-T造成死亡 4-1BB CAR-T或成行业共识, objectType=article, longId=83106, objectId=8eb28310628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eb28310628, replyNumber=0, likeNumber=62, createdTime=2017-03-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eb28310628, moduleTitle=Juno CD28 CAR-T造成死亡 4-1BB CAR-T或成行业共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8eb28310628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781132, encodeId=239f1e8113217, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T疗法明年有望进入临床应用, objectType=article, longId=85454, objectId=963c8545493, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=963c8545493, replyNumber=0, likeNumber=61, createdTime=2017-11-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=963c8545493, moduleTitle=CAR-T疗法明年有望进入临床应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=963c8545493)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781176, encodeId=831c1e8117649, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=美国食药监局正式批准诺华公司CAR-T疗法，系全球首例, objectType=article, longId=111487, objectId=17ca11148e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ca11148e2c, replyNumber=0, likeNumber=182, createdTime=2018-04-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ca11148e2c, moduleTitle=美国食药监局正式批准诺华公司CAR-T疗法，系全球首例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17ca11148e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781149, encodeId=5c921e8114901, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=OncoImmunology：广州生物院在肺癌CAR-T细胞临床前评估研究中取得进展, objectType=article, longId=92605, objectId=c6259260551, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6259260551, replyNumber=0, likeNumber=67, createdTime=2017-09-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6259260551, moduleTitle=OncoImmunology：广州生物院在肺癌CAR-T细胞临床前评估研究中取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6259260551)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781165, encodeId=05331e8116505, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T不行的“实体瘤”，巨噬细胞免疫疗法有了“新战绩”, objectType=article, longId=105890, objectId=4db210589030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4db210589030, replyNumber=0, likeNumber=56, createdTime=2017-08-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4db210589030, moduleTitle=CAR-T不行的“实体瘤”，巨噬细胞免疫疗法有了“新战绩”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4db210589030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781156, encodeId=c14d1e8115606, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=梳理CAR-T细胞疗法研究新近进展, objectType=article, longId=98395, objectId=64c598395cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64c598395cb, replyNumber=0, likeNumber=78, createdTime=2017-12-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64c598395cb, moduleTitle=梳理CAR-T细胞疗法研究新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64c598395cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【招募患者】首都医科大学附属友谊医院CD19 CAR-T细胞免疫治疗免费患者招募

2017-12-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

JCO:依鲁替尼失败后，CLL患者采用CAR-T治疗可行吗？

2017-12-04

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

NEJM:报道！CAR-T让这种淋巴瘤的脑转移完全缓解

2017-11-26

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cancer Discov：这项新发现有望减少CAR-T疗法副作用

2018-06-11

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nat Nanotechnol：重磅！利用纳米颗粒在体内制造CAR-T细胞

2018-03-24

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

FDA批准又一通用型CAR-T疗法进入临床试验

2017-09-03

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

诺华CAR- T疗法今日获美国FDA优先审评资格

2017-04-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

诺华CAR-T CTL019再获突破性疗法认定

2017-08-12

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T技术成功治愈两名ALL婴儿患者

2017-03-11

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T疗法上市之争已打响，全程自动化将是下一个爆发点

2017-09-25

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

重磅！全球第二个CAR-T疗法获批上市！

2017-12-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nature深度好文：女神告诉你，CRISPR让CAR-T继续“开车”

2017-09-14

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T疗法假如定价65万美元合理吗？

2017-06-03

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

数据公布，诺华新一代CAR-T疗法CTL119取得优异疗效

2017-11-13

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Juno CD28 CAR-T造成死亡 4-1BB CAR-T或成行业共识

2017-03-28

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T疗法明年有望进入临床应用

2017-11-26

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

美国食药监局正式批准诺华公司CAR-T疗法，系全球首例

2018-04-06

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

OncoImmunology：广州生物院在肺癌CAR-T细胞临床前评估研究中取得进展

2017-09-01

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T不行的“实体瘤”，巨噬细胞免疫疗法有了“新战绩”

2017-08-26

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

梳理CAR-T细胞疗法研究新近进展

2017-12-04

科室
- - 订阅+
  - 更多科室
工具
服务